IL3RA and leukemia: In particular, leukaemia-engrafted mice treated with either CAR.CD123-NK cells or CAR.CD123-T cells showed a significantly improved OS compared to mice treated with control conditions (NT-T or NT-NK cells; Fig. 5D).